Om oss

Ledning och styrelse

Ledning

Berit Lindholm

Chief Executive Officer


Född 1965
Anställd sedan 2015

Yrkeslivserfarenhet

COO Bluefish Pharmaceuticals AB

Head of Planning, AstraZeneca Sweden Operations, Business Relationship Director Operations IT AstraZeneca, Director Global Project and Change Management AstraZeneca, Plant Manager Sterile Solutions Freeze dried products AstraZeneca AB, Manager CMC & Labelling QA/QC Pharmacia & Upjohn Pharma Mälardalen

Utbildning
BSc Pharm, Faculty of Pharmacy Uppsala University
Helsinki University - Faculty of Pharmacy
University of Warwick - Warwick Business School, UK 

Grzegorz Harackiewicz

Business Development Director


Född 1976
Anställd sedan 2014

Yrkeslivserfarenhet
External Manufacturing and Technology Transfers Director, Polpharma Group, Head of External Manufacturing, Polpharma Group, Technology Services Department Manager, Polpharma S.A., Contract Manufacturing Manager, Polpharma S.A.,   Business Development Project Manager, Polpharma S.A. 

Utbildning
University of Gdansk, Chemistry Department, Master of Science
Gdansk Foundation for Management Development / RSM Erasmus University, MBA 

Kim Kjornas

VP - North Europe  

 

Född 1955

Anställd sedan 2017

 

Yrkeslivserfarenhet

Executive Director Sales & Marketing, Actavis

Director Business Development and in-licensing, Alpharma

Director Sales& Marketing, Polypeptide Laboratories

 

Utbildning

M.Sc. Pharm. University of Copenhagen

Lean six-sigma (green belt)

Bachelor (HH) Accounting and Economics (Koebmandsskolen Copenhagen)

Statistics for experimenters (University of Copenhagen)

Ramon Vila

VP - South Europe 

 

Född 1976

Anställd sedan 2013

 

Yrkesliverfarenhet

EU Commercial & Operations Director, FARMALIDER/ASCENDIS 

Director S&M Western Europe, ACTAVIS 

Director Portfolio & Business Development, ACTAVIS Spain

Head of S&M & Business Development, Combix (ITALFARMACO/CHEMO).

Head of Portfolio & Business Development, SANDOZ 

Business Development Management, HEXAL

Reg. Affairs & QA Manager, HEXAL

 

Utbildning

Bachelor Pharmacy (University Madrid & Universität Bonn). 

M. Sc. Pharm (CESIF, Madrid)

Executive MBA (IE Business School). 

Cranfield School of Management (UK Cranfield University)

 


Styrelse

Gerald Engström

Ordförande


Född 1948
Styrelseledamot sedan 2010
VD och koncernchef, Systemair AB

Utbildning
Gymnasieingenjör
Ekonomistudier, Stockholms universitet

Övriga styrelseuppdrag
VD: Systemair AB, Repant ASA,
Färna Invest AB

Aktieinnehav i Bluefish: 28 862 983 [1]



[1] Innehav privat och via bolag per 31 december 2015

Erika Kjellberg Eriksson

Styrelseledamot


Född 1962
Styrelseledamot sedan 2012
Partner Nexttobe AB

Utbildning
MBA
 
Övriga styrelseuppdrag
Styrelseordförande: Capilet Genetics AB, Lokon Pharma AB och Zetcity AB
Ledamot: Linum AB, Lumina Adhesives AB, Q-linea AB och Tanea Medical AB


Aktieinnehav i Bluefish: -

Nivedan Bharadwaj

Styrelseledamot


Född 1970
Styrelseledamot sedan 2012

Styrelseuppdrag
Styrelsemedlem Trustess for Fortune Institute of International Business, New Delhi, Indien.

Yrkeslivserfarenhet
Debts & Equity Group, Merrill Lynch, New York, USA.
Grundare av Fortune Stones Ltd., ett gruvbolag som drivs som ett joint venture med den indiska staten som delägare.
 
Utbildning
Owner/President Management Program vid Harvard Business School, Boston, USA.

 
Aktieinnehav i Bluefish: 3 250 000 [1]

 

[1] Innehav privat och via bolag per 31 december 2013

Karl Karlsson

Board Director

Born 1974
Founder of Bluefish Pharmaceuticals and Bord Director since 2005

Professional experience

President and CEO of Bluefish Pharmaceuticals 2005-2017

RDA Interactive LLC, 1997-2002, New York, USA
 
Education
Studies- Owner/President Management Program
at Harvard Business School, Boston, USA
Studies in Marketing and Business Administration,
George Mason University, Virginia, USA

Shareholding in Bluefish: 7 720 000
Holdings of options in Bluefish: 330 000